Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia

Researchers recently discovered that an inhibitory brain receptor triggers synaptic pruning in adolescence. Drugs that selectively target these receptors, when administered during adolescence, can alter synapse number, with possible implications for the treatment of autism and schizophrenia.